Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECYCLE
2016-004191-22Phase 4Terminated
- Sponsor
- Palleos Healthcare
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palbociclib, fulvestrant, anastrozole, letrozole, exemestane in breast cancer, sponsored by Palleos Healthcare. Started Mar 2017; status: terminated.
02
Drugs
palbociclibfulvestrantanastrozoleletrozoleexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-004191-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004191-22.